Acceleron Commences $100M Offering of Common Stock
January 21, 2014 at 06:33 AM EST
Acceleron Pharma (NASDAQ: XLRN ) today announced that it has commenced an underwritten public offering of $100 million of its common stock. All of the shares in the offering are to be
